USANA Health Sciences, Inc. (USNA)
NYSEConsumer StaplesPackaged FoodsSnapshot 2026-11-04
NYSEConsumer StaplesPackaged FoodsSnapshot 2026-11-04
QuarterlyIQ Insights · USNA
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -6.7% |
| Our one-year growth estimate | diamond | 2.4% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 9.1 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name has been missing across recent quarters and has erratic recent earnings surprises. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 10 industry peers · Company calendar date is not available
USNA — earnings miss
Dated 2026-11-03
Results of Operations and Financial Condition. On November 3, 2026, USANA Health Sciences, Inc. (the “Company” or “USANA”) issued a press release announcing its financial results for the third quarter ended October 3, 2026. The release also announced that the Company will post a document titled “Management Commentary” on the Company’s website and that executives of the Company will hold a conference call with investors, to be broadcast over the World Wide Web and by telephone and provided acc…
Why it matters: Adjusted EBITDA fell 9% year over year in Q2. Another decline would add pressure after the company cut its yearly outlook.
Worry ifQ3 adjusted EBITDA is below $27.8 million, the Q2 result.
Less concerning ifQ3 adjusted EBITDA is above $27.8 million. The company keeps its $87 million full-year outlook.
Why it matters: Hiya sales and subscribers fell 17% in Q2. Management cited weak digital ads and cut its sales outlook.
Watch forHiya active monthly subscribers grow year over year, and sales stop falling year over year.
Also watch forHiya subscribers remain down at least 17% year over year, or sales fall at least 17%.
Why it matters: Core sales and active customers fell year over year in Q2. A rebound would show the main business is stabilizing.
Watch forQ3 Core Nutritional sales and active customers both rise year over year.
Also watch forQ3 Core Nutritional sales fall at least 4% year over year, or active customers fall at least 8%.
Why it matters: Rise sales fell 75% from Q1 after a packaging problem. Its 2026 sales outlook fell to $35 million.
Watch forRise sales rise sequentially in Q3 and the company reports that the packaging issue is fixed.
Also watch forRise sales stay at or below $3 million in Q3, or management reports more packaging delays.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$172 on $10,000 · ±1.7% | How much price usually moves either way. |
| Bad day | $423 loss on $10,000 · 4.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,466 loss on $10,000 · 44.7% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: USANA amended its credit agreement on September 30. The filing can show whether debt terms or borrowing duties changed.
Worry ifThe October 5 filing shows more debt, stricter loan terms, or new borrowing duties tied to the change.
Less concerning ifThe filing shows no increase in debt, no tighter lending terms, and no added borrowing duties.
Why it matters: USANA cut its full-year sales outlook from $925 million–$1.0 billion to $910 million. Q3 results will test that revised target.
Watch forOn November 3, USANA keeps its $910 million sales outlook. Q3 sales support that outlook.
Also watch forUSANA cuts its $910 million sales outlook, or Q3 sales miss the pace needed to reach it.